(Johnson & Johnson) Johnson & Johnson posted total sales of $23.3 billion in the third quarter of 2021, up 10.7% from the prior year. US sales amounted to $11.963 billion,…
Johnson & Johnson stock flat ahead of the Q3 report.Q3 earnings and revenue are expected to top estimates.Focus on medical devices, consumer health, and pharmaceutical businesses. Johnson & Johnson (NYSE:…
(Johnson & Johnson) Vaccine maker Johnson & Johnson expects $2.5 billion sales in its Covid-19 vaccine amidst doubts of its effectiveness against the delta variant. The company reported $23.31 billion in…
U.S top court has rejected an appeal by Johnson & Johnson to pay $2.1 billion to women as ordered by a St. Louis jury, according to Bloomberg. The compensatory award…
Johnson & Johnson reported revenue of $22.48 billion in the fourth quarter, more than expected $21.67 billion, according to the company’s press release. The company reported earnings per share of…